132 related articles for article (PubMed ID: 27073883)
1. Glioma Stemlike Cells Enhance the Killing of Glioma Differentiated Cells by Cytotoxic Lymphocytes.
Bassoy EY; Chiusolo V; Jacquemin G; Riccadonna C; Walker PR; Martinvalet D
PLoS One; 2016; 11(4):e0153433. PubMed ID: 27073883
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy targeting glioma stem cells--insights and perspectives.
Li Z; Lee JW; Mukherjee D; Ji J; Jeswani SP; Black KL; Yu JS
Expert Opin Biol Ther; 2012 Feb; 12(2):165-78. PubMed ID: 22200324
[TBL] [Abstract][Full Text] [Related]
3. ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449.
Sloan AE; Nock CJ; Ye X; Buerki R; Chang S; Lesser G; Norden A; Cloughesy T; Olson J; Kerstetter-Fogle A; Rich J; Fisher J; Desideri S; Takebe N; Timmer W; Grossman S; Prados M
J Neurooncol; 2023 Jan; 161(1):33-43. PubMed ID: 36581779
[TBL] [Abstract][Full Text] [Related]
4. Pterostilbene suppressed irradiation-resistant glioma stem cells by modulating GRP78/miR-205 axis.
Huynh TT; Lin CM; Lee WH; Wu AT; Lin YK; Lin YF; Yeh CT; Wang LS
J Nutr Biochem; 2015 May; 26(5):466-75. PubMed ID: 25736407
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a human glioblastoma stemlike brainstem rodent tumor model.
Siu IM; Tyler BM; Chen JX; Eberhart CG; Thomale UW; Olivi A; Jallo GI; Riggins GJ; Gallia GL
J Neurosurg Pediatr; 2010 Jul; 6(1):92-7. PubMed ID: 20593994
[TBL] [Abstract][Full Text] [Related]
6. Stem-like tumor-initiating cells isolated from IL13Rα2 expressing gliomas are targeted and killed by IL13-zetakine-redirected T Cells.
Brown CE; Starr R; Aguilar B; Shami AF; Martinez C; D'Apuzzo M; Barish ME; Forman SJ; Jensen MC
Clin Cancer Res; 2012 Apr; 18(8):2199-209. PubMed ID: 22407828
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Power-Law Growth in the Self-Renewal of Heterogeneous Glioma Stem Cell Populations.
Sugimori M; Hayakawa Y; Boman BM; Fields JZ; Awaji M; Kozano H; Tamura R; Yamamoto S; Ogata T; Yamada M; Endo S; Kurimoto M; Kuroda S
PLoS One; 2015; 10(8):e0135760. PubMed ID: 26284929
[TBL] [Abstract][Full Text] [Related]
8. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
9. Sulindac induces differentiation of glioblastoma stem cells making them more sensitive to oxidative stress.
Allani SK; Weissbach H; Lopez Toledano MA
Neoplasma; 2018 Mar; 65(3):376-388. PubMed ID: 29788733
[TBL] [Abstract][Full Text] [Related]
10. Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing.
Riccadonna C; Yacoub Maroun C; Vuillefroy de Silly R; Boehler M; Calvo Tardón M; Jueliger S; Taverna P; Barba L; Marinari E; Pellegatta S; Bassoy EY; Martinvalet D; Dietrich PY; Walker PR
PLoS One; 2016; 11(8):e0162105. PubMed ID: 27579489
[TBL] [Abstract][Full Text] [Related]
11. Identification and isolation of slow-cycling glioma stem cells.
Furst L; Atkins RJ; Dinevska M; Stylli SS; Corcoran NM; Hovens CM; Mantamadiotis T
Methods Cell Biol; 2022; 170():21-30. PubMed ID: 35811101
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of glioma stem cells.
Sampetrean O; Saya H
Brain Tumor Pathol; 2013 Oct; 30(4):209-14. PubMed ID: 23584571
[TBL] [Abstract][Full Text] [Related]
13. The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence.
Auffinger B; Spencer D; Pytel P; Ahmed AU; Lesniak MS
Expert Rev Neurother; 2015; 15(7):741-52. PubMed ID: 26027432
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cells and glioma.
Das S; Srikanth M; Kessler JA
Nat Clin Pract Neurol; 2008 Aug; 4(8):427-35. PubMed ID: 18628751
[TBL] [Abstract][Full Text] [Related]
15. ER-mitochondria contacts control surface glycan expression and sensitivity to killer lymphocytes in glioma stem-like cells.
Bassoy EY; Kasahara A; Chiusolo V; Jacquemin G; Boydell E; Zamorano S; Riccadonna C; Pellegatta S; Hulo N; Dutoit V; Derouazi M; Dietrich PY; Walker PR; Martinvalet D
EMBO J; 2017 Jun; 36(11):1493-1512. PubMed ID: 28283580
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol promotes proteasome-dependent degradation of Nanog via p53 activation and induces differentiation of glioma stem cells.
Sato A; Okada M; Shibuya K; Watanabe E; Seino S; Suzuki K; Narita Y; Shibui S; Kayama T; Kitanaka C
Stem Cell Res; 2013 Jul; 11(1):601-10. PubMed ID: 23651583
[TBL] [Abstract][Full Text] [Related]
17. Frontiers in targeting glioma stem cells.
Frosina G
Eur J Cancer; 2011 Mar; 47(4):496-507. PubMed ID: 21185169
[TBL] [Abstract][Full Text] [Related]
18. Increased in vivo angiogenic effect of glioma stromal mesenchymal stem-like cells on glioma cancer stem cells from patients with glioblastoma.
Kong BH; Shin HD; Kim SH; Mok HS; Shim JK; Lee JH; Shin HJ; Huh YM; Kim EH; Park EK; Chang JH; Kim DS; Hong YK; Kim SH; Lee SJ; Kang SG
Int J Oncol; 2013 May; 42(5):1754-62. PubMed ID: 23483121
[TBL] [Abstract][Full Text] [Related]
19. β-elemene inhibits stemness, promotes differentiation and impairs chemoresistance to temozolomide in glioblastoma stem-like cells.
Zhu TZ; Li XM; Luo LH; Song ZQ; Gao X; Li ZQ; Su JY; Liang GB
Int J Oncol; 2014 Aug; 45(2):699-709. PubMed ID: 24841897
[TBL] [Abstract][Full Text] [Related]
20. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
